ZA918719B - Ester inhibitors - Google Patents

Ester inhibitors

Info

Publication number
ZA918719B
ZA918719B ZA918719A ZA918719A ZA918719B ZA 918719 B ZA918719 B ZA 918719B ZA 918719 A ZA918719 A ZA 918719A ZA 918719 A ZA918719 A ZA 918719A ZA 918719 B ZA918719 B ZA 918719B
Authority
ZA
South Africa
Prior art keywords
ester inhibitors
inhibitors
ester
Prior art date
Application number
ZA918719A
Other languages
English (en)
Inventor
Gary Paul Kirschenheuter
Paul Kirschenheuter Gary
John Chris Cheronis
Chris Cheronis John
Raymond Thomas Cunningham
Thomas Cunningham Raymond
Original Assignee
Cortech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cortech Inc filed Critical Cortech Inc
Publication of ZA918719B publication Critical patent/ZA918719B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/337—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Indole Compounds (AREA)
ZA918719A 1990-11-07 1991-11-01 Ester inhibitors ZA918719B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61020790A 1990-11-07 1990-11-07

Publications (1)

Publication Number Publication Date
ZA918719B true ZA918719B (en) 1992-08-26

Family

ID=24444115

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA918719A ZA918719B (en) 1990-11-07 1991-11-01 Ester inhibitors

Country Status (14)

Country Link
EP (1) EP0484949A3 (pt)
JP (1) JPH04283576A (pt)
KR (1) KR920009820A (pt)
CN (1) CN1061152A (pt)
AU (1) AU647838B2 (pt)
CA (1) CA2054953A1 (pt)
FI (1) FI915232A (pt)
HU (1) HUT60246A (pt)
IE (1) IE913880A1 (pt)
IL (1) IL99953A0 (pt)
NO (1) NO175818C (pt)
NZ (1) NZ240442A (pt)
PT (1) PT99439A (pt)
ZA (1) ZA918719B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795890A (en) * 1995-09-27 1998-08-18 Ono Pharmaceutical Co., Ltd. Sulfonamide derivatives
WO1997049679A1 (fr) * 1996-06-27 1997-12-31 Ono Pharmaceutical Co., Ltd. Derives d'aryle (sulfure, oxyde sulfonique et sulfone) et medicaments les contenant en tant que principe actif
US6379587B1 (en) 1999-05-03 2002-04-30 Betzdearborn Inc. Inhibition of corrosion in aqueous systems
US6585933B1 (en) 1999-05-03 2003-07-01 Betzdearborn, Inc. Method and composition for inhibiting corrosion in aqueous systems
MXPA01011087A (es) * 1999-05-03 2002-06-04 Betzdearborn Inc Metodo y composicion para inhibir la corrosion en sistemas acuosos.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1564081A (pt) * 1968-03-08 1969-04-18
IE33054B1 (en) * 1968-04-16 1974-03-06 Ici Ltd Heterocyclic compounds
US4146721A (en) * 1969-09-12 1979-03-27 Byk Gulden Lomberg Chemische Fabrik Gmbh Pyrazol-4-acetic acid compounds
US4683241A (en) * 1984-05-21 1987-07-28 G. D. Searle & Co. Phenolic ester derivatives as elastase inhibitors
ATE67180T1 (de) * 1985-11-12 1991-09-15 Ono Pharmaceutical Co P-guanidinbenzoesaeurederivate und pharmazeutische mittel, die sie als aktiven inhaltsstoff enthalten.
GB8826035D0 (en) * 1988-11-07 1988-12-14 Ici Plc Herbicidal compositions
US5214191A (en) * 1990-05-22 1993-05-25 Cortech, Inc. Oxidant sensitive and insensitive aromatic esters as inhibitors of human neutrophil elastase

Also Published As

Publication number Publication date
IE913880A1 (en) 1992-05-20
AU8694291A (en) 1992-05-14
PT99439A (pt) 1992-09-30
NO914349D0 (no) 1991-11-06
JPH04283576A (ja) 1992-10-08
AU647838B2 (en) 1994-03-31
HU913491D0 (en) 1992-01-28
IL99953A0 (en) 1992-08-18
CN1061152A (zh) 1992-05-20
KR920009820A (ko) 1992-06-25
EP0484949A2 (en) 1992-05-13
NO175818C (no) 1994-12-14
CA2054953A1 (en) 1992-05-08
NO914349L (no) 1992-05-08
FI915232A0 (fi) 1991-11-06
EP0484949A3 (en) 1993-01-20
FI915232A (fi) 1992-05-08
NZ240442A (en) 1994-11-25
NO175818B (no) 1994-09-05
HUT60246A (en) 1992-08-28

Similar Documents

Publication Publication Date Title
SG46381A1 (en) Leukoriene biiosynthese inhibitor
ZA917096B (en) Enzyme inhibitors
EP0474540A3 (en) Scale inhibitor for calcium-type scale
HU9400952D0 (en) Heteroaryl-amines as acetyl-cholinesterase inhibitors
AU8292091A (en) Tnf inhibitors
ZA916449B (en) Pyrimidyl-substituted acrylic esters
GB2257256B (en) Plastometer
ZA921840B (en) Triazinyl-substituted acrylic esters
ZA914555B (en) 2-methoximinocarboxylic esters
EP0563238A4 (en) Imidazolyl-alkenoic acids
EP0558659A4 (en) Tnf inhibitors
ZA919058B (en) Sulfimidoperoxycarboxylic acids
IL99953A0 (en) Ester inhibitors
EP0539043A3 (en) Novel esters
EP0543936A4 (en) Renin inhibitors
HK1005311A1 (en) Phenylbicyclohexanol ester derivative
GB9304619D0 (en) Esters
IL103938A0 (en) Novel phenylsulfonylacrylate ester derivatives
GB9026251D0 (en) Netalloproteinase inhibitors
GB9121278D0 (en) Ester
GB9218762D0 (en) Esters
GB2272370B (en) An easel
GB9007750D0 (en) Enzyme inhibitors
ZA914716B (en) Ace inhibitors
ZA916059B (en) Tnf inhibitors